All lobbying filings

IONIS PHARMACEUTICALS, INC.

Lobbying for IONIS PHARMACEUTICALS, INC. · Biotechnology company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $150,000.00 expenses · posted Jul 17, 2026

Official filing document

Bills named in this filing 4

HR 1672
Maintaining Investments in New Innovation Act
HR 1414
Cameron’s Law
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 3

Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.

Taxation/Internal Revenue Code

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Health Issues

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.